Stefan Merlo

Stefan Merlo has been Vice President, Commercial Development at CSL Seqirus since 2021, overseeing the business unit’s long-term strategy. In his role, Stefan leads a team that enhances the commercial value of our existing vaccines while optimizing our future portfolio through internal and external development. 

Stefan began his career as a retail pharmacist, later moving into the biopharmaceutical industry where he has spent the past 20 years. Stefan joined CSL Seqirus upon CSL’s 2015 acquisition of Novartis Vaccines’ influenza business, where he played a key role in shaping the growth trajectory of the business as Executive Director, Sales and Account Management in the US. 

Stefan received his Doctor of Pharmacy degree from Northeastern University.